Circulating tumor DNA as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis
{{output}}
Objective: Circulating tumor DNA (ctDNA) is increasingly being used as a potential prognosis biomarker in patients of breast cancer. This review aims to assess the clinical value of ctDNA in outcome prediction in breast cancer pa... ...
